- JP-listed companies
- BrightPath Biotherapeutics Co., Ltd.
- Income statement
BrightPath Biotherapeutics Co., Ltd.JP:4594
Market cap
¥4.5B
P/E ratio
-3.7x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 195 | 451 | 933 | 822 | 823 | 530 | 354 | 156 | 11 | 3 | 15 | 5 | 0 | 1 |
| Cost of revenue | - | - | - | 767 | 772 | 525 | 315 | 71 | 4 | 1 | 3 | 2 | 0 | 0 |
| Gross profit | - | - | - | 55 | 51 | 5 | 39 | 85 | 7 | 1 | 12 | 3 | 0 | 1 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | -492 | -989 | -1,114 | -1,562 | -1,666 | -1,827 | -1,733 | -1,476 | -1,467 | -1,155 | -1,161 |
| Operating expenses | - | - | - | 547 | 1,040 | 1,118 | 1,601 | 1,751 | 1,834 | 1,734 | 1,488 | 1,470 | 1,155 | 1,162 |
| Income before tax | 30 | 220 | 19 | -414 | -993 | -1,117 | -1,573 | -1,678 | -1,824 | -1,739 | -1,482 | -1,474 | -1,159 | -1,148 |
| Provision for income taxes | - | - | - | 4 | 1 | 5 | 5 | 4 | -2 | 2 | 2 | 2 | 2 | 2 |
| Net income | 28 | 218 | 17 | -412 | -994 | -1,114 | -1,577 | -1,884 | -1,858 | -1,720 | -1,484 | -1,486 | -1,168 | -1,151 |
| Earnings per share | 2.33 | 18.22 | 1.46 | -20.6 | -35.28 | -32.74 | -41.25 | -44.95 | -44.2 | -36.14 | -28.55 | -24.9 | -18.21 | -14.12 |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |